Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' GOUYETTE A' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 57 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Santos, A; Zanetta, S; Cresteil, T; Deroussent, A; Pein, F; Raymond, E; Vernillet, L; Risse, ML; Boige, V; Gouyette, A; Vassal, G
      Metabolism of irinotecan (CPT-11) by CYP3A4 and CYP3A5 in humans

      CLINICAL CANCER RESEARCH
    2. Vandier, D; Rixe, O; Besnard, F; Kim, M; Rikiyama, T; Goldsmith, M; Brenner, M; Gouyette, A; Cowan, KH
      Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter

      CANCER GENE THERAPY
    3. Monneret, C; Risse, S; Ardouin, P; Gouyette, A
      Synthesis and antitumour activity of a new series of nitrosoureido sugars

      EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
    4. Queiroz, EF; Roblot, F; Duret, P; Figadere, B; Gouyette, A; Laprevote, O; Serani, L; Hocquemiller, R
      Synthesis, spectroscopy, and cytotoxicity of glycosylated acetogenin derivatives as promising molecules for cancer therapy

      JOURNAL OF MEDICINAL CHEMISTRY
    5. Vandier, D; Calvez, V; Massade, L; Gouyette, A; Mickley, L; Fojo, T; Rixe, O
      Transactivation of the metallothionein promoter in cisplatin-resistant cancer cells: a specific gene therapy strategy

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    6. Le Ray, AM; Iooss, P; Gouyette, A; Vonarx, V; Patrice, T; Merle, C
      Development of a "continuous-flow adhesion cell" for the assessment of hydrogel adhesion

      DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
    7. Sereni, D; Tubiana, R; Lascoux, C; Katlama, C; Taulera, O; Bourque, A; Cohen, A; Dvorchik, B; Martin, RR; Tournerie, C; Gouyette, A; Schechter, PJ
      Pharmacokinetics and tolerability of intravenous Trecovirsen (GEM (R) 91),an antisense phosphorothioate oligonucleotide, in HIV-positive subjects

      JOURNAL OF CLINICAL PHARMACOLOGY
    8. Boland, I; Vassal, G; Morizet, J; Terrier-Lacombe, MJ; Valteau-Couanet, D; Kalifa, C; Hartmann, O; Gouyette, A
      Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

      BRITISH JOURNAL OF CANCER
    9. VASSAL G; BOLAND I; TERRIERLACOMBE MJ; WATSON AJ; MARGISON GP; VENUAT AM; MORIZET J; PARKER F; LACROIX C; LELLOUCHTUBIANA A; PIERREKAHN A; POULLAIN MG; GOUYETTE A
      ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY

      Clinical cancer research
    10. VASSAL G; BOLAND I; TERRIERLACOMBE MJ; WATSON AJ; MARGISON GP; VENUAT AM; MORIZET J; PARKER F; LACROIX C; LELLOUCHTUBIANA A; PIERREKAHN A; POULLAIN MG; GOUYETTE A
      ACTIVITY OF FOTEMUSTINE IN MEDULLOBLASTOMA AND MALIGNANT GLIOMA XENOGRAFTS IN RELATION TO O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE AND ALKYLPURINE-DNA N-GLYCOSYLASE ACTIVITY

      Clinical cancer research
    11. GOUYETTE A
      TOPOISOMERASES - FOREWORD

      Biochimie
    12. VASSAL G; PONDARRE C; BOLAND I; CAPPELLI C; SANTOS A; THOMAS C; LUCCHI E; IMADALOU K; PEIN F; MORIZET J; GOUYETTE A
      PRECLINICAL DEVELOPMENT OF CAMPTOTHECIN DERIVATIVES AND CLINICAL-TRIALS IN PEDIATRIC ONCOLOGY

      Biochimie
    13. MASSAADMASSADE L; CHOUAIB S; GOUYETTE A
      PHENOBARBITAL PREVENTS THE INHIBITORY EFFECTS OF TUMOR-NECROSIS-FACTOR ON GLUTATHIONE-S-TRANSFERASE-MU IN PRIMARY CULTURE RAT HEPATOCYTES

      Anticancer research
    14. MASSAADMASSADE L; DOMENGE C; RONGEAT S; HASSOUN L; LEGROS MH; ROPERS J; JANOT F; PARISE O; GOUYETTE A
      RED-BLOOD-CELL GLUTATHIONE LEVELS BEFORE AND DURING TREATMENT WITH NEOADJUVANT CHEMOTHERAPY CISPLATIN 5-FLUOROURACIL IN PATIENTS WITH HEAD AND NECK SQUAMOUS-CELL CARCINOMA/

      Anticancer research
    15. VANDIER D; RIXE O; BRENNER M; GOUYETTE A; BESNARD F
      SELECTIVE KILLING OF GLIOMA CELL-LINES USING AN ASTROCYTE-SPECIFIC EXPRESSION OF THE HERPES-SIMPLEX VIRUS THYMIDINE KINASE GENE

      Cancer research
    16. LENEEL T; MORLETRENAUD C; LIPART C; GOUYETTE A; TRUCHAUD A; MERLE C
      IMAGE-ANALYSIS AS A NEW TECHNIQUE FOR THE STUDY OF WATER-UPTAKE IN TABLETS

      STP pharma sciences
    17. EMERIT I; FILIPE P; MEUNIER P; AUCLAIR C; FREITAS J; DEROUSSENT A; GOUYETTE A; FERNANDES A
      CLASTOGENIC ACTIVITY IN THE PLASMA OF SCLERODERMA PATIENTS - A BIOMARKER OF OXIDATIVE STRESS

      Dermatology
    18. MORLET L; VONARX V; FOULTIER MT; GOUYETTE A; STEWART C; LENZ P; PATRICE T
      IN-VITRO AND IN-VIVO SPECTROFLUOROMETRY OF A WATER-SOLUBLE META-(TETRAHYDROXYPHENYL)CHLORIN (M-THPC) DERIVATIVE

      Journal of photochemistry and photobiology.B, Biology
    19. VASSAL G; PONDARRE C; CAPPELLI C; TERRIERLACOMBE MJ; BOLAND I; MORIZET J; BENARD J; VENUAT AM; ARDOUIN P; HARTMANN O; GOUYETTE A
      DNA-TOPOISOMERASE-I, A NEW TARGET FOR THE TREATMENT OF NEUROBLASTOMA

      European journal of cancer
    20. MASSAADMASSADE L; RIBRAG V; MARIE JP; FAUSSAT AM; BAYLE C; DREYFUS F; GOUYETTE A
      GLUTATHIONE SYSTEM, TOPOISOMERASE-II LEVEL AND MULTIDRUG-RESISTANCE PHENOTYPE IN ACUTE MYELOGENOUS LEUKEMIA BEFORE TREATMENT AND AT RELAPSE

      Anticancer research
    21. VONARX V; ELEOUET S; CARRE J; IOSS P; GOUYETTE A; LERAY AM; MERLE C; LAJAT Y; PATRICE T
      POTENTIAL EFFICACY OF A DELTA-5-AMINOLEVULINIC ACID BIOADHESIVE GEL FORMULATION FOR THE PHOTODYNAMIC TREATMENT OF LESIONS OF THE GASTROINTESTINAL-TRACT IN MICE

      Journal of Pharmacy and Pharmacology
    22. VASSAL G; BOLAND I; SANTOS A; BISSERY MC; TERRIERLACOMBE MJ; MORIZET J; SAINTEROSE C; LELLOUCHTUBIANA A; KALIFA C; GOUYETTE A
      POTENT THERAPEUTIC ACTIVITY OF IRINOTECAN (CPT-11) AND ITS SCHEDULE DEPENDENCY IN MEDULLOBLASTOMA XENOGRAFTS IN NUDE-MICE

      International journal of cancer
    23. ALBIN N; MASSADE L; GOUYETTE A
      USE AND APPLICATIONS OF PHARMACOGENETICS IN ONCOLOGY AND HEMATOLOGY

      Bulletin du cancer
    24. RIBRAG V; MASSADE L; FAUSSAT AM; DREYFUS F; BAYLE C; GOUYETTE A; MAIRE JP
      DRUG-RESISTANCE MECHANISMS IN CHRONIC LYMPHOCYTIC-LEUKEMIA

      Leukemia
    25. RAMIREZ LH; ZHAO ZX; ROUGIER P; BOGNEL C; DZODIC R; VASSAL G; ARDOUIN P; GOUYETTE A; MUNCK JN
      PHARMACOKINETICS AND ANTITUMOR EFFECTS OF MITOXANTRONE AFTER INTRATUMORAL OR INTRAARTERIAL HEPATIC ADMINISTRATION IN RABBITS

      Cancer chemotherapy and pharmacology
    26. VASSAL G; KOSCIELNY S; CHALLINE D; VALTEAUCOUANET D; BOLAND I; DEROUSSENT A; LEMERLE J; GOUYETTE A; HARTMANN O
      BUSULFAN DISPOSITION AND HEPATIC VENOOCCLUSIVE DISEASE IN CHILDREN UNDERGOING BONE-MARROW TRANSPLANTATION

      Cancer chemotherapy and pharmacology
    27. MARANINCHI D; BARBET J; BATTAIS J; EMILIE D; GOEHRS JM; GUINOT P; MANNONI P; MEYER P; ROMETLEMONNE JL; TROUVIN JH; CALVO F; GALANAUD P; GOUYETTE A; JULOU CL; MARCEL T; MOREL A; QUENTINMILLET MJ; SCHATZ C; WIJDENES J
      WHICH STATUS FOR DRUGS OF BIOLOGICAL ORIG IN

      Therapie
    28. VASSAL G; TERRIERLACOMBE MJ; LELLOUCHTUBIANA A; VALERY CA; SAINTEROSE C; MORIZET J; ARDOUIN P; RIOU G; KALIFA C; GOUYETTE A
      TUMORIGENICITY OF CEREBELLAR PRIMITIVE NEURO-ECTODERMAL TUMORS IN ATHYMIC MICE CORRELATES WITH POOR-PROGNOSIS IN CHILDREN

      International journal of cancer
    29. VASSAL G; TERRIERLACOMBE MJ; BISSERY MC; VENUAT AM; GYERGYAY F; BENARD J; MORIZET J; BOLAND I; ARDOUIN P; BRESSACDEPAILLERETS B; GOUYETTE A
      THERAPEUTIC ACTIVITY OF CPT-11, A DNA-TOPOISOMERASE-I INHIBITOR, AGAINST PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR AND NEUROBLASTOMA XENOGRAFTS

      British Journal of Cancer
    30. RIBRAG V; MASSAAD L; JANOT F; MORIZET J; GOUYETTE A; CHABOT GG
      MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN NON-HODGKINS-LYMPHOMASSENSITIVE OR RESISTANT TO CHEMOTHERAPY

      Leukemia & lymphoma
    31. VONARXCOINSMAN V; FOULTIER MT; DEBRITO LX; MORLET L; GOUYETTE A; PATRICE T
      HEPG2 HUMAN HEPATOCARCINOMA CELLS - AN EXPERIMENTAL-MODEL FOR PHOTOSENSITIZATION BY ENDOGENOUS PORPHYRINS

      Journal of photochemistry and photobiology.B, Biology
    32. DOMENGE C; MASSADE L; RONGEAT S; HASSOUN L; LEGROS MH; JANOT F; JULIERON M; LUBOINSKI B; GOUYETTE A
      GLUTATHIONE SYSTEM AND CHEMORESPONSE TO 5-FLUOROURACIL AND CISPLATINEIN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - A PILOT-STUDY

      European journal of cancer
    33. DEROUSSENT A; LECAER JP; ROSSIER J; GOUYETTE A
      ELECTROSPRAY MASS-SPECTROMETRY FOR THE CHARACTERIZATION OF THE PURITYOF NATURAL AND MODIFIED OLIGODEOXYNUCLEOTIDES

      Rapid communications in mass spectrometry
    34. CATIMEL G; CHABOT GG; GUASTALLA JP; DUMORTIER A; COTE C; ENGEL C; GOUYETTE A; MATHIEUBOUE A; MAHJOUBI M; CLAVEL M
      PHASE-I AND PHARMACOKINETIC STUDY OF IRINOTECAN (CPT-11) ADMINISTEREDDAILY FOR 3 CONSECUTIVE DAYS EVERY 3 WEEKS IN PATIENTS WITH ADVANCED SOLID TUMORS

      Annals of oncology
    35. ABIGERGES D; CHABOT GG; ARMAND JP; HERAIT P; GOUYETTE A; GANDIA D
      PHASE-I AND PHARMACOLOGICAL STUDIES OF THE CAMPTOTHECIN ANALOG IRINOTECAN ADMINISTERED EVERY 3 WEEKS IN CANCER-PATIENTS

      Journal of clinical oncology
    36. DEFORNI M; CHABOT GG; ARMAND JP; GOUYETTE A; KLINKALAK M; RECONDO G
      PHASE-I AND PHARMACOLOGY STUDY OF FLAVONE ACETIC-ACID ADMINISTERED 2 OR 3 TIMES WEEKLY WITHOUT ALKALINIZATION

      Cancer chemotherapy and pharmacology
    37. LECESNE A; CHABOT G; BERILLE J; LUCAS C; BAUD M; GOUYETTE A; MARTY M; LECHEVALIER T
      PHASE I-II AND PHARMACOKINETIC STUDY OF A NEW FOTEMUSTINE SCHEDULE INADVANCED NON-SMALL-CELL LUNG-CANCER

      Lung cancer
    38. RAMIREZ LH; JULIERON M; BONNAY M; KOSCIELNY S; ZHAO ZX; GOUYETTE A; MUNCK JN
      STIMULATION OF TUMOR-GROWTH IN-VITRO AND IN-VIVO BY SURAMIN ON THE VX2 MODEL

      Investigational new drugs
    39. GORDON BH; BAKES DM; BENNETT P; LEBRAS B; WALTHER B; LUCAS C; MARC S; GOUYETTE A
      METHODS FOR THE ANALYSIS OF THE NEW VINCA ALKALOID DERIVATIVE, S-12363, IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION

      Journal of chromatography B. Biomedical applications
    40. PARISE O; JANOT F; LUBOINSKI B; MASSAAD L; ALBIN N; TOUSSAINT C; VERJUS MA; BONNAY M; GOUYETTE A; CHABOT GG
      THYMIDYLATE SYNTHASE ACTIVITY, FOLATES, AND GLUTATHIONE SYSTEM IN HEAD AND NECK-CARCINOMA AND ADJACENT TISSUES

      Head & neck
    41. MUNCK JN; ROUGIER P; CHABOT GG; RAMIREZ LH; BOGNEL C; LUMBROSO J; HERAIT P; ELIAS D; LASSER P; GOUYETTE A
      PHASE-I AND PHARMACOLOGICAL STUDY OF INTRAARTERIAL HEPATIC ADMINISTRATION OF PIRARUBICIN IN PATIENTS WITH ADVANCED HEPATIC METASTASES

      European journal of cancer
    42. MASSAAD L; CHABOT GG; TOUSSAINT C; KOSCIELNY S; MORIZET J; BISSERY MC; GOUYETTE A
      INFLUENCE OF TUMOR SIZE ON THE MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN MOUSE COLON ADENOCARCINOMA CO38

      Cancer chemotherapy and pharmacology
    43. RIBRAG V; MASSAAD L; JANOT F; BISSERY MC; PARISE O; GOUYETTE A; CHABOT GG
      PRINCIPAL DRUG-METABOLIZING ENZYME-SYSTEMS IN L1210 LEUKEMIA SENSITIVE OR RESISTANT TO BCNU IN-VIVO

      Leukemia research
    44. VASSAL G; PEIN F; GOUYETTE A; LEMERLE J
      DEVELOPMENT OF NEW ANTICANCER AGENTS IN C HILDREN - METHODOLOGY, DIFFICULTIES, AND STRATEGIES

      Annales de pediatrie
    45. DEFORNI M; BUGAT R; CHABOT GG; CULINE S; EXTRA JM; GOUYETTE A; MADELAINE I; MARTY ME; MATHIEUBOUE A
      PHASE-I AND PHARMACOKINETIC STUDY OF THE CAMPTOTHECIN DERIVATIVE IRINOTECAN, ADMINISTERED ON A WEEKLY SCHEDULE IN CANCER-PATIENTS

      Cancer research
    46. RAMIREZ LH; MUNCK JN; ZHAO ZX; BOGNEL C; RICARD M; ARDOUIN P; ROUGIER P; GOUYETTE A
      VERAPAMIL-REVERSING CONCENTRATIONS INDUCE BLOOD-FLOW CHANGES THAT COULD COUNTERACT IN-VIVO THE MDR-1-MODULATING EFFECTS

      Cancer
    47. VASSAL G; BOLAND I; DEROUSSENT A; GEORGIN D; NOEL JP; GOUYETTE A
      IN-VITRO BUSULFAN METABOLISM IN HUMAN AND MOUSE-LIVER

      Bulletin du cancer
    48. GOUYETTE A
      GLUTATHIONE-LINKED DRUG-RESISTANCE

      Bulletin du cancer
    49. DEFORNI M; CHABOT GG; ARMAND JP; FONTANA X; RECONDO G; DOMENGE C; CARDE P; BARBU M; GOUYETTE A
      PHASE-I AND PHARMACOKINETIC STUDY OF BREQUINAR (DUP-785 NSC-368390) IN CANCER-PATIENTS

      European journal of cancer
    50. RIBRAG V; DROZ JP; MORIZET J; LECLERCQ B; GOUYETTE A; CHABOT GG
      TEST DOSE-GUIDED ADMINISTRATION OF CISPLATIN IN AN ANEPHRIC PATIENT -A CASE-REPORT

      Annals of oncology
    51. GOUYETTE A
      NEW TECHNIQUES IN THE PHARMACOKINETIC ANALYSIS OF CANCER DRUGS .1. MASS-SPECTROMETRY - RECENT TECHNICAL DEVELOPMENTS AND APPLICATIONS IN CANCER-CHEMOTHERAPY

      Cancer surveys
    52. JANOT F; MASSAAD L; RIBRAG V; DEWAZIERS I; BEAUNE PH; LUBOINSKI B; PARISE O; GOUYETTE A; CHABOT GG
      PRINCIPAL XENOBIOTIC-METABOLIZING ENZYME-SYSTEMS IN HUMAN HEAD AND NECK SQUAMOUS-CELL CARCINOMA

      Carcinogenesis
    53. TOUSSAINT C; ALBIN N; MASSAAD L; GRUNENWALD D; PARISE O; MORIZET J; GOUYETTE A; CHABOT GG
      MAIN DRUG-METABOLIZING AND CARCINOGEN-METABOLIZING ENZYME-SYSTEMS IN HUMAN NONSMALL CELL LUNG-CANCER AND PERITUMORAL TISSUES

      Cancer research
    54. ALBIN N; MASSAAD L; TOUSSAINT C; MATHIEU MC; MORIZET J; PARISE O; GOUYETTE A; CHABOT GG
      MAIN DRUG-METABOLIZING ENZYME-SYSTEMS IN HUMAN BREAST-TUMORS AND PERITUMORAL TISSUES

      Cancer research
    55. MASSAAD L; DEWAZIERS I; RIBRAG V; JANOT F; MORIZET J; BEAUNE PH; GOUYETTE A; CHABOT GG
      SCREENING OF MAIN DRUG-METABOLIZING-ENZYMES IN MOUSE AND HUMAN COLON TUMORS

      Bulletin du cancer
    56. RAMIREZ LH; MUNCK JN; BOGNEL C; ZHAO Z; ARDOUIN P; POUPON MF; GOUYETTE A; ROUGIER P
      PHARMACOLOGY AND ANTITUMOR EFFECTS OF INTRAPORTAL PIRARUBICIN ON EXPERIMENTAL LIVER METASTASES

      British Journal of Cancer
    57. VASSAL G; FISCHER A; CHALLINE D; BOLAND I; LEDHEIST F; LEMERLE S; VILMER E; RAHIMY C; SOUILLET G; GLUCKMAN E; MICHEL G; DEROUSSENT A; GOUYETTE A
      BUSULFAN DISPOSITION BELOW THE AGE OF 3 - ALTERATION IN CHILDREN WITHLYSOSOMAL STORAGE DISEASE

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 12:15:41